Reduced Heart Failure Rehospitalization at 1 Year for Patients Managed Using a Radiofrequency-Based Sensor
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker’s Bureau - BioVentrix; Boston Scientific Corporation; Impulse Dynamics Inc.; Medtronic; Nanowear, Inc.; Zoll Medical Corporation
- Grant Support/Research Contract - V-Wave; Ancora Heart, Inc.